Laura Stoppel

Insider Reports History

Location
Charlottesville, VA
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Stoppel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. Director Common Stock 12,800 $14,080 $1.10 04 Jun 2025 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 19,500 04 Jun 2025 Direct
Artiva Biotherapeutics, Inc. Director Director Stock Option (Right to Buy) 13,750 24 Jun 2025 Direct

Insider Reports Filed by Laura Stoppel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARTV Artiva Biotherapeutics, Inc. 24 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:30
ABOS Acumen Pharmaceuticals, Inc. 04 Jun 2025 2 $0 4 Director 05 Jun 2025, 18:05
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 Director 18 Jul 2024, 20:05
ABOS Acumen Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:51
ABOS Acumen Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:44
ABOS Acumen Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:27
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:21
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 Director 30 Jun 2021, 19:01